Advances in Lymphoma Research by Peter McLaughlin, Lester E. Robertson, Michael J. Keating

By Peter McLaughlin, Lester E. Robertson, Michael J. Keating (auth.), Fernando Cabanillas M.D., M. Alma Rodriguez M.D. (eds.)

Fernando Cabanillas In 1993, Fisher et al. released the result of a randomized trial evaluating 3 third-generation regimens opposed to the vintage CHOP mixture. For a number of years, the oncology neighborhood have been confident that the 3rd­ iteration regimens have been sincerely more suitable to cut. It got here as a surprise to many who there has been no distinction in consequence among the 4 hands of this scientific trial. The logical end is that CHOP is nearly as good as any of the opposite regimens verified in that examine. regrettably, this wonderful examine has been misinterpreted via many as proving that there has now not been any growth within the box of lymphoma over the last twenty years. additionally, it has resulted in a fatalistic angle within the reasoning of many clinicians who suppose that 'nothing works higher than CHOP' and for that reason that it's not worthy checking out new medicinal drugs or constructing novel regimens. even though, the method during which we circulate ahead within the oncology box is seldom through dramatic breakthroughs. usually, what seems at the beginning look to be a leap forward seems later to be only a modest breakthrough. numerous steps ahead finally upload as much as a big develop, yet this improve is going left out a result of gradual nature of the method. during this quantity, we have now selected to debate a number of of those steps, which we think are in actual fact creating a confident effect at the box of lymphomas and which quickly should still make an important distinction in healing results.

Show description

Read or Download Advances in Lymphoma Research PDF

Similar research books

Research Agendas in EU Studies: Stalking the Elephant (Palgrave Studies in European Union Politics)

Top students discover the advanced questions bobbing up from the continued transformation of Europe during the deepening and widening results of eu integration. according to authoritative analyses, the ebook takes account of the numerous nationwide, transnational and overseas techniques and contexts within which ecu integration has turn into embedded.

Perspectives on Scientific Argumentation: Theory, Practice and Research

Argumentation—arriving at conclusions on a subject matter via a strategy of logical reasoning that comes with debate and persuasion— has in recent times emerged as a primary subject of debate between technological know-how educators and researchers. there's now an organization and basic trust that fostering argumentation in studying actions can advance scholars’ serious pondering and reasoning abilities, and that dialogic and collaborative inquiries are key precursors to an engagement in medical argumentation.

Ciba Foundation Symposium 134 - Research and the Ageing Population

This foreign symposium makes a speciality of the contributions that biomedical examine is making to the supply of right future health take care of the expanding numbers of aged humans in all international locations, constructed and constructing. contemporary, encouraging advancements within the parts of malignancy, dementia, osteoporosis, and heart problems are emphasised.

Additional resources for Advances in Lymphoma Research

Sample text

Proc Am Soc Clin Oncol 8:276 (abstract). 48. Hochester HS, Kim K, Green MD, et al. (1992). Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: results of an Eastern Cooperative Oncology Group Study. J Clin Oncol 10:28-32. 49. Duggan DB, Anderson JR, Dillman R, Case P, Gottlieb AJ (1990). 2'deoxycoformycin (pentostatin) for refractory non-Hodgkin's lymphoma: a CALGB phase II study. Med Pediatr Oncol 18:203-206. 50. Kantarjian HM, Alexanian R, Koller C, et al. (1990). Fludarabine therapy in macroglobulinemic lymphomas.

After the Lukes-Butler classification was published and became widely accepted, it was noted by a number of authors that the histologic features of NSHD could include sheets of lacunar cells [12-15]. Butler had termed this feature as 'lacunar cell predominant' or 'the syncytial variant' of NSHD. Strickler elaborated on this feature with immunoperoxidase staining to differentiate 'the syncytial variant' of NSHD from other entities such as large cell Evolution to Grades I and II NSHD Seven categories of NSHD [4] 23 Categories of NSHD [4] a Two clinically significant categories of NSHD [1] lP lP, MC MC MC, Pleo MClD, fa MClD lD NSHDI NSHD II Abbreviations Full Description lP NSHD, lymphocyte predominant lP, MC NSHD, lymphocyte predominant-mixed cellularity MC NSHD, mixed cellularity MC, Pleo NSHD, mixed cellularity, pleomorphic MClD, f NSHD, mixed cellularity with areas of lymphocyte depletion comprising bland fibrohistiocytic depletion.

NSHD II. Pleomorphic lymphocyte depleted. The Hodgkin's cells in the nodule are pleomorphic. Lymphocytes are depleted, but there are polymorphonuclear leukocytes and histiocytes in the background. 33 Figure 5. NSHD II. The Hodgkin's cells in the nodule are pleomorphic with large nuclei containing prominent nucleoli, but the background lymphocytes are not depleted. (figure 1) by the presence of large, variably sized hyperchromatic nuclei with large prominent nucleoli. , NSHD II histology are not met, a case of NSHD under review would be classified as NSHD I [1].

Download PDF sample

Rated 4.59 of 5 – based on 3 votes